“At a meeting hosted by the Pakistan Drug Control Administration (Drap) Registration Board, another vaccine was approved for use in an emergency — a drug developed with the support of the Russian Direct Investment Fund,” he said.

The importer and distributor of the vaccine will be the local pharmaceutical company AGP.

Sputnik V is the third vaccine approved in Pakistan, after the British-Swedish company AstraZeneca and the University of Oxford, as well as the Chinese company Sinopharm.

On January 22, it was reported that Pakistan had received a request to register the Sputnik V vaccine.